Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Acta cir. bras ; 31(2): 133-137, Feb. 2016. graf
Artículo en Inglés | LILACS | ID: lil-775559

RESUMEN

PURPOSE: To investigate the role of adenosine A2A receptors on 6-OHDA-induced motor disorder in rat. METHODS: In order to induce experimental model of Parkinson's disease, 6-hydoxydopamine (8 μg/rat) was injected unilaterally into the SNc. After three weeks as a recovery period, 6-OHDA-induced bradykinesia and balance disturbances were assessed by using beam traversal test 10, 30 and 60 minutes after intraperitoneal injections of the drugs (caffeine, SCH58261). RESULTS: The results showed that 6-OHDA (8 μg/rat, Intra-SNc) induced motor disorders of Parkinson's disease and increased elapsed time in the beam test (p<0.001). Injection of caffeine (30 mg/kg, i.p.) and SCH58261 (2 mg/kg, i.p.) attenuated elapsed time on beam (p<0.01 and p<0.001). We showed that acute administration of caffeine and SCH 58261 can improve the 6-OHDA-induced bradykinesia and motor disturbance. CONCLUSION: Adenosine A2AR antagonists improve 6-OHDA-motor deficit and this effect seems to be mediated by the inhibition of A2A presynaptic receptors in substantia nigra pars compacta.


Asunto(s)
Animales , Masculino , Enfermedad de Parkinson Secundaria/inducido químicamente , Cafeína/farmacología , Oxidopamina/efectos adversos , Antagonistas de Receptores Purinérgicos P1/farmacología , Antagonistas del Receptor de Adenosina A2/farmacología , Estudios de Tiempo y Movimiento , Ratas Wistar , Hipocinesia/inducido químicamente , Modelos Animales de Enfermedad , Trastornos Motores/inducido químicamente , Actividad Motora/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA